Topical versus systemic vancomycin for deep sternal wound infection caused by methicillin-resistant Staphylococcus aureus in a rodent experimental model

Texas Heart Institute Journal

Volumn 33, Issue 2, 2006, Pages 107-110

  Ozcan, Ali V ^a,c   Demir, Melek ^a   Onem, Gokhan ^a   Goksin, Ibrahim ^a   Baltalarli, Ahmet ^a   Topkara, Veli K ^b   Kaleli, Ilknur ^a  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Department of Surgery ^*  (Turkey)

Author keywords

Anti bacterial agents therapeutic use; Drug resistance, bacterial; Mediastinitis prevention control; Postoperative care; Rats; Staphylococcal infections drug therapy prevention control; Sternum surgery

Indexed keywords

KETAMINE; VANCOMYCIN; VANKOMISIN; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; EXPERIMENTAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RAT; STERNOTOMY; STERNUM; TREATMENT OUTCOME; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-BACTERIAL AGENTS; INFUSIONS, INTRAVENOUS; MALE; METHICILLIN RESISTANCE; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STEM CELLS; STERNUM; SURGICAL WOUND INFECTION; VANCOMYCIN;

EID: 33748085388     PISSN: 07302347     EISSN: 07302347     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. El Oakley RM, Wright JE. Postoperative mediastinitis: classification and management. Ann Thorac Surg 1996;61: 1030-6.
2. Satta J, Lahtinen J, Raisanen L, Salmela E, Juvonen T. Options for the management of poststernotomy mediastinitis. Scand Cardiovasc J 1998;32:29-32.
3. Vander Salm TJ, Okike ON, Pasque MK, Pezzella AT, Lew R, Traina V, Mathieu R. Reduction of sternal infection by application of topical vancomycin. J Thorac Cardiovasc Surg 1989;98:618-22.
4. Losanoff JE, Richman BW, Jones JW. Disruption and infection of median sternotomy: a comprehensive review. Eur J Cardiothorac Surg 2002;21:831-9.
5. De Feo M, Gregorio R, Della Corte A, Marra C, Amarelli C, Renzulli A, et al. Deep sternal wound infection: the role of early debridement surgery. Eur J Cardiothorac Surg 2001; 19:811-6.
6. Weinzweig N, Yetman R. Transposition of the greater omentum for recalcitrant median sternotomy wound infections. Ann Plast Surg 1995;34:471-7.
7. Nahai F, Rand RP, Hester TR, Bostwick J 3rd, Jurkiewicz MJ. Primary treatment of the infected sternotomy wound with muscle flaps: a review of 211 consecutive cases. Plast Reconstr Surg 1989;84:434-41.
8. Entenza JM, Vouillamoz J, Glauser MP, Moreillon P. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci. Antimicrob Agents Chemother 2004;48:86-92.
9. Gardlund B, Bitkover CY, Vaage J. Postoperative mediastinitis in cardiac surgery - microbiology and pathogenesis. Eur J Cardiothorac Surg 2002;21:825-30.
10. Fekety R. Vancomycin and teicoplanin. In: Mandell GL, Douglas RG, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 346-54.
11. Aldaz A, Ortega A, Idoate A, Giraldez J, Brugarolas A. Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer. Ther Drug Monit 2000;22:250-7.
12. Desmond J, Lovering A, Harle C, Djorevic T, Millner R. Topical vancomycin applied on closure of the sternotomy wound does not prevent high levels of systemic vancomycin. Eur J Cardiothorac Surg 2003;23:765-70.
13. Ikeda H, Kurisu K, Kihira K. Vancomycin ointment for MRSA infection at a cranioplasty site. Ann Pharmacother 2004;38:70-2.
14. Ross J, Abate MA. Topical vancomycin for the treatment of Staphylococcus epidermidis and methicillin-resistant Staphylococcus aureus conjunctivitis. DICP 1990;24:1050,1053.
15. Jang CH, Song CH, Wang PC. Topical vancomycin for chronic suppurative otitis media with methicillin-resistant Staphylococcus aureus otorrhoea. J Laryngol Otol 2004;118:645-7.
16. Bernard L, Vaudaux P, Vuagnat A, Stern R, Rohner P, Pittet D, et al. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance. Infect Control Hosp Epidemiol 2003;24:650-4.
17. Shumacker HB Jr, Mandelbaum I. Continuous antibiotic irrigation in the treatment of infection. Arch Surg 1963;86:384-7.
18. Merrill WH, Akhter SA, Wolf RK, Schneeberger EW, Flege JB Jr. Simplified treatment of postoperative mediastinitis. Ann Thorac Surg 2004;78:608-12.
19. Ahmed A, Jafri H, Lutsar I, McCoig CC, Trujillo M, Wubbel L, et al. Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1999;43:876-81.
20. Oakley RE, Nimer KA, Bukhari E. Is the use of topical vancomycin to prevent mediastinitis after cardiac surgery justified? J Thorac Cardiovasc Surg 2000;119:190-1.
21. Sieradzki K, Roberts RB, Haber SW, Tomasz A. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med 1999;340:517-23.
22. Krivoy N, Yanovsky B, Kophit A, Zaher A, Bar-El Y, Adler Z, et al. Vancomycin sequestration during cardiopulmonary bypass surgery. J Infect 2002;45:90-5.